Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands

[1]  H. Tobi,et al.  Parents report on stimulant-treated children in the Netherlands: initiation of treatment and follow-up care. , 2006, Journal of child and adolescent psychopharmacology.

[2]  C. McDougle,et al.  Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. , 2005, Archives of general psychiatry.

[3]  H. Tobi,et al.  Recruitment of parents and physicians of stimulant-using children via community pharmacies is successful. , 2005, Journal of Clinical Epidemiology.

[4]  F. Gesten,et al.  Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population. , 2005, Journal of child and adolescent psychopharmacology.

[5]  T. Uchiyama,et al.  The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning Pervasive Developmental Disorder (PDD) , 2004, European Child & Adolescent Psychiatry.

[6]  S. Goldstein,et al.  The Comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: Results of a Retrospective Chart Review , 2004, Journal of autism and developmental disorders.

[7]  M. DelBello,et al.  Phenomenology and epidemiology of childhood psychiatric disorders that may necessitate treatment with atypical antipsychotics. , 2004, The Journal of clinical psychiatry.

[8]  J. Buitelaar,et al.  International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions , 2004, European Neuropsychopharmacology.

[9]  D. Sclar,et al.  Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99 , 2004, International clinical psychopharmacology.

[10]  C. Gillberg,et al.  Co–existing disorders in ADHD – implications for diagnosis and intervention , 2004, European Child & Adolescent Psychiatry.

[11]  J. Buitelaar,et al.  European clinical guidelines for hyperkinetic disorder – first upgrade , 2004, European Child & Adolescent Psychiatry.

[12]  Andrés Martin,et al.  Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. , 2003, Psychiatric services.

[13]  R. Reid,et al.  Use of psychostimulant medication for ADHD in South Australia. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[14]  C. McDougle,et al.  Risperidone in children with autism and serious behavioral problems. , 2002, The New England journal of medicine.

[15]  M. Sawyer,et al.  Use of medication by young people with attention‐deficit/hyperactivity disorder , 2002, The Medical journal of Australia.

[16]  M. Weissman,et al.  National trends in the use of psychotropic medications by children. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  J. Urquhart,et al.  Automated Pharmacy Record Linkage in The Netherlands , 2002 .

[18]  C. Lalonde,et al.  Prescription of methylphenidate to children and youth, 1990-1996. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[19]  Subcommittee on Attention-Deficit,et al.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. , 2001, Pediatrics.

[20]  M. Olfson,et al.  Prescription of psychotropic medications to youths in office-based practice. , 2001, Psychiatric services.

[21]  H. Tobi,et al.  Psychotropic medication in children: a study from the Netherlands. , 2001, Pediatrics.

[22]  J. Buitelaar,et al.  A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. , 2001, The Journal of clinical psychiatry.

[23]  H. Kraemer,et al.  ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[24]  F. Lynch,et al.  Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care. , 2001, Journal of child and adolescent psychopharmacology.

[25]  P. Accardo,et al.  What's all the fuss about Ritalin? , 2001, The Journal of pediatrics.

[26]  F. Volkmar,et al.  How unspecified are disorders of children with a pervasive developmental disorder not otherwise specified? A study of social problems in children with PDD-NOS and ADHD , 2000, European Child & Adolescent Psychiatry.

[27]  D. Safer.  Are Stimulants Overprescribed for Youths with ADHD? , 2000, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[28]  F. Lynch,et al.  Trends in the prescribing of psychotropic medications to preschoolers. , 2000, JAMA.

[29]  K. Kelleher,et al.  Treatment services for children with ADHD: a national perspective. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[30]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[31]  L. Magder,et al.  Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. , 1999, Archives of pediatrics & adolescent medicine.

[32]  R Tannock,et al.  Sleep problems in children with attention-deficit/hyperactivity disorder: impact of subtype, comorbidity, and stimulant medication. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[33]  T. Clark,et al.  Autistic symptoms in children with attention deficit-hyperactivity disorder , 1999, European Child & Adolescent Psychiatry.

[34]  M. Dulcan,et al.  Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  C. King,et al.  Suicidal adolescents after hospitalization: parent and family impacts on treatment follow-through. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.